DaVita, Inc. (DVA)
187.83
-1.33
(-0.70%)
USD |
NYSE |
Oct 16, 15:18
DaVita SG&A Expense (TTM) : 1.732B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.732B |
| March 31, 2026 | 1.721B |
| December 31, 2025 | 1.674B |
| September 30, 2025 | 1.616B |
| June 30, 2025 | 1.595B |
| March 31, 2025 | 1.550B |
| December 31, 2024 | 1.538B |
| September 30, 2024 | 1.525B |
| June 30, 2024 | 1.509B |
| March 31, 2024 | 1.505B |
| December 31, 2023 | 1.474B |
| September 30, 2023 | 1.452B |
| June 30, 2023 | 1.441B |
| March 31, 2023 | 1.392B |
| December 31, 2022 | 1.355B |
| September 30, 2022 | 1.298B |
| June 30, 2022 | 1.226B |
| March 31, 2022 | 1.209B |
| December 31, 2021 | 1.195B |
| September 30, 2021 | 1.177B |
| June 30, 2021 | 1.247B |
| March 31, 2021 | 1.265B |
| December 31, 2020 | 1.248B |
| September 30, 2020 | 1.221B |
| June 30, 2020 | 1.157B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.116B |
| December 31, 2019 | 1.103B |
| September 30, 2019 | 1.093B |
| June 30, 2019 | 1.131B |
| March 31, 2019 | 1.120B |
| December 31, 2018 | 1.135B |
| September 30, 2018 | 1.132B |
| June 30, 2018 | 1.069B |
| March 31, 2018 | 1.068B |
| December 31, 2017 | 1.064B |
| September 30, 2017 | 1.211B |
| June 30, 2017 | 1.345B |
| March 31, 2017 | 1.469B |
| December 31, 2016 | 1.593B |
| September 30, 2016 | 1.589B |
| June 30, 2016 | 1.536B |
| March 31, 2016 | 1.501B |
| December 31, 2015 | 1.456B |
| September 30, 2015 | 1.403B |
| June 30, 2015 | 1.373B |
| March 31, 2015 | 1.319B |
| December 31, 2014 | 1.262B |
| September 30, 2014 | 1.224B |
| June 30, 2014 | 1.207B |
| March 31, 2014 | 1.176B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Quest Diagnostics, Inc. | 2.038B |
| Labcorp Holdings, Inc. | 2.219B |
| Lifestance Health Group, Inc. | 398.86M |
| Progyny, Inc. | 209.96M |
| Acadia Healthcare Co., Inc. | 208.76M |